The data show that up to now, 94 A-share listed companies have disclosed the annual performance forecast of 2021, of which 77 are pre happy, with a proportion of 81.91%.

Among the 94 listed companies, 32 increased slightly, 2 reversed losses, 10 continued profits and 33 increased in advance. The listed companies that have disclosed the performance forecast have maintained a high performance growth as a whole.

From the perspective of industry, the performance of media, chemical industry, medical and pharmaceutical, electronics, transportation, communication technology and other industries is more prominent.

77 companies' annual performance forecast

In terms of the amount of net profit, it is estimated that 42 companies will realize the lower limit of net profit attributable to the parent company of more than 100 million yuan in 2021, 13 companies are expected to realize the lower limit of net profit attributable to the parent company of more than 500 million yuan, and 6 listed companies such as Focus Media Information Technology Co.Ltd(002027) , Lb Group Co.Ltd(002601) , Goertek Inc(002241) , Jiangsu Shuangxing Color Plastic New Materials Co.Ltd(002585) , DEA shares and Haili wind power are expected to realize the lower limit of net profit attributable to the parent company of more than 1 billion yuan in 2021.

Among them, Focus Media Information Technology Co.Ltd(002027) is expected to realize a net profit attributable to the parent company of RMB 6.02 billion to RMB 6.2 billion in 2021, with a year-on-year increase of 50.36% to 54.85%. The company has maintained a sustained and stable growth trend in the field of consumer goods. At the same time, benefiting from the base effect, the operating performance of the company in 2021 increased significantly compared with last year.

In terms of net profit growth, excluding the loss recovery companies, it is expected that 49 companies will realize the lower limit of return to parent net profit growth of more than 10% and 25 companies will achieve more than 50% in 2021. 11 listed companies, including Dongxin shares, Eternal Asia Supply Chain Management Ltd(002183) , Baolingbao Biology Co.Ltd(002286) , Jiahe Meikang, Henan Liliang Diamond Co.Ltd(301071) , Juxin technology-u, Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) , DEA shares, Guangdong Hybribio Biotech Co.Ltd(300639) , Puya Semiconductor (Shanghai) Co.Ltd(688766) , Lb Group Co.Ltd(002601) , are expected to achieve a lower limit of return to parent net profit growth of more than 100% in 2021.

With a net profit increase of more than 10 times, Dongxin shares is temporarily listed as the "growth king" of the annual performance of A-Shares in 2021. According to the prospectus of the company's initial public offering and listing on the science and innovation board, the company expects to realize a net profit attributable to the parent of RMB 225 million to RMB 240 million in 2021. In 2020, the company realized a net profit attributable to the parent company of 19.5331 million yuan.

outstanding performance in chemical and electronic industries

From the perspective of industry, the performance of chemical industry, electronics, medical and pharmaceutical, media, transportation, communication technology and other industries is relatively outstanding.

In terms of communication technology, according to the data of the Ministry of industry and information technology, new achievements have been made in the high-quality development of the information and communication industry. More than 1.3 million 5g base stations have been built and opened, and 497 million 5g end users have been established, exceeding the annual task of accurate fee reduction of telecommunications.

In the medical and pharmaceutical industry, listed companies in nucleic acid testing products have outstanding performance. Guangdong Hybribio Biotech Co.Ltd(300639) it is estimated that the net profit attributable to the parent company will reach RMB 800 million to RMB 860 million in 2021, with a year-on-year increase of 120.59% to 137.14%. During the reporting period, the company continued to promote the integrated business model of "nucleic acid testing products + medical testing services", and continued to implement the "nucleic acid 99 strategy" and "Kemp B53 nucleic acid remote strategic service scheme". The company's third-party Medical Laboratory (including Hong Kong) actively participated in covid-19 epidemic prevention and control, and its business achieved rapid development.

According to the data released by the Ministry of industry and information technology, the support tasks of vaccines and important medical materials have been fully completed, and the annual production capacity of covid-19 vaccine has reached 7 billion doses.

The reporter of China Securities Journal found that the industry in which the enterprise is located is in a high business cycle, the sales volume of new products has increased significantly after listing, and the company's orders on hand have increased, which is the main reason for the performance growth.

Yunlu Co., Ltd., an advanced magnetic metal material enterprise, is expected to realize an operating revenue of about 890 million yuan to 960 million yuan in 2021, with a year-on-year increase of 24.43% to 34.21%; It is estimated that the net profit attributable to the parent company will be RMB 113 million to RMB 125 million in 2021, with a year-on-year increase of 17.9% to 30.42%. During the reporting period, the sales volume of the company's new products nanocrystalline ultra-thin belt, atomized powder and its products increased significantly after marketing, driving the growth of the company's performance.

Lb Group Co.Ltd(002601) it is pointed out in the performance forecast that the company expects to realize a net profit attributable to the parent company of 4577.3732 million yuan to 5721.7165 million yuan in 2021, with a year-on-year increase of 100% to 150%. The main reason for the performance change is that during the reporting period, the titanium dioxide market, the company's main product, was in a business cycle, the sales price increased significantly year-on-year, the utilization rate of the existing titanium dioxide capacity was improved, especially the effective release of the company's chlorination capacity.

annual report nuggets

89 shares took the lead in the "spoiler" annual report, and nearly 80% of the company was pleased

2021 annual report performance first! More than 80% of the results are expected to double the profits of 12 stocks

(China Securities Journal)